Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

7.86
-0.0500-0.63%
Post-market: 7.860.00000.00%19:30 EDT
Volume:164.46K
Turnover:1.31M
Market Cap:237.81M
PE:-1.36
High:8.27
Open:8.11
Low:7.79
Close:7.91
52wk High:11.00
52wk Low:5.60
Shares:30.26M
Float Shares:12.40M
Volume Ratio:1.39
T/O Rate:1.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7983
EPS(LYR):-5.0200
ROE:-7029.26%
ROA:-17.43%
PB:-1.90
PE(LYR):-1.57

Loading ...

Cartesian Therapeutics Shareholders Back Directors and Governance Measures

TIPRANKS
·
Jun 18

Cartesian Therapeutics shareholders elect Class I director slate at annual meeting

Reuters
·
Jun 18

Cartesian Therapeutics grants new hire stock option for 6,100 shares at $5.86

Reuters
·
Jun 13

Cartesian Therapeutics Announces New Employment Inducement Grant

GlobeNewswire
·
Jun 13

Wedbush Sticks to Their Buy Rating for Cartesian Therapeutics (RNAC)

TIPRANKS
·
Jun 11

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Cartesian Therapeutics (RNAC) and Abbott Laboratories (ABT)

TIPRANKS
·
Jun 10

Cartesian Therapeutics Price Target Maintained With a $44.00/Share by BTIG

Dow Jones
·
Jun 10

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

Cartesian Therapeutics Shares Rise on Licensing Deal for WestGene Delivery Platform

Dow Jones
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Nuvalent, Sirius XM, J.M. Smucker

Reuters
·
Jun 09

Cartesian Therapeutics Announces In Vivo CAR-T Licensing Alliance

TIPRANKS
·
Jun 09

BUZZ-Cartesian rises on China tie-up to develop new autoimmune cell therapy

Reuters
·
Jun 09

Cartesian Therapeutics - Westgene to Receive Upfront and Potential Milestone Payments Under Agreement

THOMSON REUTERS
·
Jun 09

Cartesian Therapeutics - Clinical Study to Initiate 2H 2026 With in-Human Data Expected 1H 2027

THOMSON REUTERS
·
Jun 09

Cartesian Therapeutics Announces Strategic Licensing Agreement With Westgene Biopharma to Accelerate the Development of in Vivo CAR-T Platform in Autoimmune Diseases

THOMSON REUTERS
·
Jun 09

Cartesian Therapeutics - Clinical Trial With Descartes-8 Mrna and Westgene Lnp in Mg to Start 2H 2026

THOMSON REUTERS
·
Jun 09

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

GlobeNewswire
·
Jun 09

H.C. Wainwright Keeps Their Buy Rating on Cartesian Therapeutics (RNAC)

TIPRANKS
·
May 27

Cartesian Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
May 27